What are the guidelines for grouping, spacing, and numbering characters in a Sequence Listing?

The guidelines for grouping, spacing, and numbering characters in a Sequence Listing are outlined in MPEP 2423.01. Specifically, the MPEP refers to the Code of Federal Regulations for these details: “37 CFR 1.822(c) through (e) set forth the format for presenting sequence data. These paragraphs set forth the manner in which the characters in sequences…

Read More

How should ambiguity in sequences be represented in a sequence listing?

How should ambiguity in sequences be represented in a sequence listing? Ambiguity in sequences should be represented using specific symbols and annotations as outlined in MPEP 2423.01 and WIPO Standard ST.25. Here’s how to handle ambiguous positions: For nucleotides: Use “n” to represent an unknown or ambiguous base For amino acids: Use “Xaa” to represent…

Read More

How should modified and unusual amino acids be represented in a sequence listing?

The MPEP 2423.01 provides specific guidance on representing modified and unusual amino acids in a sequence listing: “Modified and unusual amino acids must be represented as the corresponding unmodified amino acids in the sequence itself but may be further described in the feature section of the sequence listing.” This means that: In the main sequence,…

Read More

What is the correct format for presenting amino acid symbols in a Sequence Listing?

According to MPEP 2423.01, the correct format for presenting amino acid symbols in a Sequence Listing is as follows: Three-letter symbols for amino acids are required in the Sequence Listing. The three-letter symbols must be presented using uppercase for the first character and lowercase for the remaining two characters. The MPEP states: “In 37 CFR…

Read More